These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 7503966

  • 1. Update on reverse transcriptase inhibitors in HIV disease.
    Carr A, Loewenthal M, Cooper DA.
    Isr J Med Sci; 1993 Oct; 29(10 Suppl):26-30. PubMed ID: 7503966
    [No Abstract] [Full Text] [Related]

  • 2. Clinical trials of combination therapies for HIV infection. Rationale for development of multidrug therapy.
    Hoth D.
    J Acquir Immune Defic Syndr (1988); 1990 Oct; 3 Suppl 2():S95-6. PubMed ID: 2172506
    [No Abstract] [Full Text] [Related]

  • 3. [Anti-HIV therapy (1987-1994): from nothing to confusion].
    Lissen E.
    Med Clin (Barc); 1995 Apr 01; 104(12):463-7. PubMed ID: 7739285
    [No Abstract] [Full Text] [Related]

  • 4. [Inhibitors of HIV-1 reverse transcriptase and protease as chemotherapeutics for AIDS].
    Mitsuya H.
    Nihon Rinsho; 1991 Sep 01; 49(9):2062-9. PubMed ID: 1720470
    [No Abstract] [Full Text] [Related]

  • 5. AZT delta study: major European/Australian study finds combinations better than AZT alone.
    King E.
    AIDS Treat News; 1995 Oct 06; (no 232):3-4. PubMed ID: 11362876
    [Abstract] [Full Text] [Related]

  • 6. [Effect of treatment with nucleoside analogues in subjects with primary genotypic resistance to zidovudine].
    Leal M, Caruz A, Rey C, Lissen E.
    Med Clin (Barc); 1996 Nov 30; 107(19):755. PubMed ID: 9082095
    [No Abstract] [Full Text] [Related]

  • 7. Data and safety monitoring in the Delta trial.
    Armitage P.
    Control Clin Trials; 1999 Jun 30; 20(3):229-41. PubMed ID: 10357496
    [Abstract] [Full Text] [Related]

  • 8. 3TC approval may revive AZT's appeal.
    Vazquez E.
    Posit Aware; 1996 Jun 30; 7(1):8-9. PubMed ID: 11363136
    [Abstract] [Full Text] [Related]

  • 9. [Anti-retroviral treatment. Treatment modification: toxicity management].
    Ocaña I, Laguna F, Pulido F, Bascuñana A.
    Enferm Infecc Microbiol Clin; 1996 Oct 30; 14 Suppl 1():31-5. PubMed ID: 9053025
    [No Abstract] [Full Text] [Related]

  • 10. Study results at a glance.
    AIDS Alert; 1995 Nov 30; 10(11):134. PubMed ID: 11362922
    [Abstract] [Full Text] [Related]

  • 11. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
    Whitfield RM, Bechtel LM, Starich GH.
    Alcohol Clin Exp Res; 1997 Feb 30; 21(1):122-7. PubMed ID: 9046384
    [Abstract] [Full Text] [Related]

  • 12. Making sense of 175 and Delta.
    Smart T.
    GMHC Treat Issues; 1995 Oct 30; 9(10):4. PubMed ID: 11362916
    [Abstract] [Full Text] [Related]

  • 13. [Nevirapine: a new principle of action against HIV].
    Dtsch Med Wochenschr; 1996 Dec 06; 121(49):A48-9. PubMed ID: 8998915
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. FDA Committee recommends clearance for HIVID combination therapy.
    AIDS Patient Care STDS; 1996 Jun 06; 10(3):186. PubMed ID: 11361630
    [No Abstract] [Full Text] [Related]

  • 16. Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine.
    Kelleher T, Cross A, Dunkle L.
    Clin Ther; 1999 Jul 06; 21(7):1182-92. PubMed ID: 10463516
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ACTG 175 and Delta.
    Torres G.
    GMHC Treat Issues; 1995 Oct 06; 9(10):2-3. PubMed ID: 11362915
    [Abstract] [Full Text] [Related]

  • 19. Back to the nukes.
    Smart T.
    GMHC Treat Issues; 1996 Feb 06; 10(2):6-7. PubMed ID: 11363383
    [Abstract] [Full Text] [Related]

  • 20. Intermittent therapy.
    Volberding PA.
    J Acquir Immune Defic Syndr (1988); 1994 May 06; 7(5):454-6. PubMed ID: 8158538
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.